EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC-ND 4.0

Corrigendum to “BRD4 inhibitor suppresses melanoma metastasis via the SPINK6 EGFR-EphA2 pathway” [Pharmacol. Res. 187 (2023) 106609]

Rui Hu, Yao Li, Ying Guo, Xin Li, Songtao Du, Mengting Liao, Huihui Hou, Hongyin Sun, Shuang Zhao, Juan Su, Xiang Chen, Mingzhu Yin

Pharmacological Research · 2026-08 · 230 · 108338

DOI: 10.1016/j.phrs.2026.108338 ↗

Kurz gefasst

Korrektur in der Zeitschrift Pharmacological Research, 2026-08. Verfasst von Rui Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya H…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The authors have informed the Journal that in the article referenced above, during the course of the revision wrong images were Fig. 6L.Specifically, an incorrect loading control panel (GAPDH) was inadvertently misplaced during figure assembly.After carefully reviewing the original data, we have confirmed that the error was limited to the loading control image and resulted from figure assembly only.The Academic Ethics Committee of the Xiangya Hospital of Central South University was asked by the Editor to check the integrity of the results sustaining the above referenced article.The Committee has checked the raw data and confirmed in writing to the journal the integrity of the data, concluding that this was a case of clerical error not modifying the interpretation of the results, asking the journal to issue an Erratum.Accordingly, the corrected version of Fig. 6L is now provided.All the authors of the article have agreed to the correction; they apologise for any inconvenience caused to the readers.

Autor:innen und Institutionen

  • Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Depa…
  • Department of Pathology, Yale School of Medicine, New Haven, CT 06520, USA.
  • Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Nati…

Zitieren

APA

Hu, R., Li, Y., Guo, Y., Li, X., Du, S., Liao, M., Hou, H., Sun, H., Zhao, S., Su, J., Chen, X., & Yin, M. (2026). Corrigendum to “BRD4 inhibitor suppresses melanoma metastasis via the SPINK6 EGFR-EphA2 pathway” [Pharmacol. Res. 187 (2023) 106609]. Pharmacological Research, 230, 108338. https://doi.org/10.1016/j.phrs.2026.108338

Vancouver

Hu R, Li Y, Guo Y, Li X, Du S, Liao M, et al. Corrigendum to “BRD4 inhibitor suppresses melanoma metastasis via the SPINK6 EGFR-EphA2 pathway” [Pharmacol. Res. 187 (2023) 106609]. Pharmacological Research. 2026;230:108338. doi:10.1016/j.phrs.2026.108338

BibTeX
@article{Hu2026,
  author = {Hu, Rui and Li, Yao and Guo, Ying and Li, Xin and Du, Songtao and Liao, Mengting and Hou, Huihui and Sun, Hongyin and Zhao, Shuang and Su, Juan and Chen, Xiang and Yin, Mingzhu},
  title = {Corrigendum to “BRD4 inhibitor suppresses melanoma metastasis via the SPINK6 EGFR-EphA2 pathway” [Pharmacol. Res. 187 (2023) 106609]},
  journal = {Pharmacological Research},
  year = {2026},
  volume = {230},
  pages = {108338},
  doi = {10.1016/j.phrs.2026.108338}
}
Kostenlos starten →